Avanos Medical Stock Retained Earnings
AVNS Stock | USD 19.15 0.34 1.74% |
Avanos Medical fundamentals help investors to digest information that contributes to Avanos Medical's financial success or failures. It also enables traders to predict the movement of Avanos Stock. The fundamental analysis module provides a way to measure Avanos Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avanos Medical stock.
Avanos |
Avanos Medical Company Retained Earnings Analysis
Avanos Medical's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Avanos Medical Retained Earnings | (314.9 M) |
Most of Avanos Medical's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Avanos Medical has a Retained Earnings of (314.9 Million). This is 133.81% lower than that of the Health Care Equipment & Supplies sector and 142.08% lower than that of the Health Care industry. The retained earnings for all United States stocks is 103.38% higher than that of the company.
Avanos Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.Avanos Medical is currently under evaluation in retained earnings category among its peers.
Avanos Fundamentals
Return On Equity | 0.0177 | ||||
Return On Asset | 0.0208 | ||||
Profit Margin | 0.02 % | ||||
Operating Margin | 0.1 % | ||||
Current Valuation | 1.01 B | ||||
Shares Outstanding | 45.96 M | ||||
Shares Owned By Insiders | 2.94 % | ||||
Shares Owned By Institutions | 94.04 % | ||||
Number Of Shares Shorted | 607.19 K | ||||
Price To Earning | 51.23 X | ||||
Price To Book | 0.73 X | ||||
Price To Sales | 1.31 X | ||||
Revenue | 673.3 M | ||||
Gross Profit | 450 M | ||||
EBITDA | 98.5 M | ||||
Net Income | (9.9 M) | ||||
Cash And Equivalents | 106.5 M | ||||
Cash Per Share | 2.26 X | ||||
Total Debt | 209.1 M | ||||
Debt To Equity | 0.24 % | ||||
Current Ratio | 2.89 X | ||||
Book Value Per Share | 26.73 X | ||||
Cash Flow From Operations | 32.4 M | ||||
Short Ratio | 3.15 X | ||||
Earnings Per Share | 0.47 X | ||||
Price To Earnings To Growth | 2.29 X | ||||
Target Price | 22.5 | ||||
Number Of Employees | 3.77 K | ||||
Beta | 0.93 | ||||
Market Capitalization | 895.7 M | ||||
Total Asset | 1.69 B | ||||
Retained Earnings | (314.9 M) | ||||
Working Capital | 252.4 M | ||||
Current Asset | 773.54 M | ||||
Current Liabilities | 415.63 M | ||||
Net Asset | 1.69 B |
About Avanos Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.